Skip to main content
. 2007 Jun 18;51(9):3381–3384. doi: 10.1128/AAC.01588-06

FIG. 1.

FIG. 1.

Clinical response results for 149 evaluable cases of S. aureus uSSSI treated with either cefdinir or cephalexin that were characterized by susceptibility to oxacillin (methicillin) and PVL production. CA-MRSA, community-acquired MRSA (6).